189 related articles for article (PubMed ID: 35139800)
1. Altered Expression and
Matrisciano F; Locci V; Dong E; Nicoletti F; Guidotti A; Grayson DR
Curr Neuropharmacol; 2022 Nov; 20(12):2354-2368. PubMed ID: 35139800
[TBL] [Abstract][Full Text] [Related]
2. Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism.
Di Menna L; Orlando R; D'Errico G; Ginerete RP; Machaczka A; Bonaccorso CM; Arena A; Spatuzza M; Celli R; Alborghetti M; Ciocca E; Zuena AR; Scioli M; Bruno V; Battaglia G; Nicoletti F; Catania MV
Neuropharmacology; 2023 Nov; 238():109642. PubMed ID: 37392820
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice.
Vicidomini C; Ponzoni L; Lim D; Schmeisser MJ; Reim D; Morello N; Orellana D; Tozzi A; Durante V; Scalmani P; Mantegazza M; Genazzani AA; Giustetto M; Sala M; Calabresi P; Boeckers TM; Sala C; Verpelli C
Mol Psychiatry; 2017 May; 22(5):689-702. PubMed ID: 27021819
[TBL] [Abstract][Full Text] [Related]
4. Histamine H3 receptor antagonism modulates autism-like hyperactivity but not repetitive behaviors in BTBR T+Itpr3tf/J inbred mice.
Molenhuis RT; Hutten L; Kas MJH
Pharmacol Biochem Behav; 2022 Jan; 212():173304. PubMed ID: 34856309
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism.
Athnaiel O; Job GA; Ocampo R; Teneqexhi P; Messer WS; Ragozzino ME
Int J Neuropsychopharmacol; 2022 Jan; 25(1):64-74. PubMed ID: 34791301
[TBL] [Abstract][Full Text] [Related]
6. 5HT
Amodeo DA; Rivera E; Cook EH; Sweeney JA; Ragozzino ME
Genes Brain Behav; 2017 Mar; 16(3):342-351. PubMed ID: 27717169
[TBL] [Abstract][Full Text] [Related]
7. Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism.
Rhine MA; Parrott JM; Schultz MN; Kazdoba TM; Crawley JN
Autism Res; 2019 Mar; 12(3):401-421. PubMed ID: 30653853
[TBL] [Abstract][Full Text] [Related]
8. The adenosine A
Amodeo DA; Cuevas L; Dunn JT; Sweeney JA; Ragozzino ME
Autism Res; 2018 Feb; 11(2):223-233. PubMed ID: 29193861
[TBL] [Abstract][Full Text] [Related]
9. Serotonin 6 receptor blockade reduces repetitive behavior in the BTBR mouse model of autism spectrum disorder.
Amodeo DA; Oliver B; Pahua A; Hitchcock K; Bykowski A; Tice D; Musleh A; Ryan BC
Pharmacol Biochem Behav; 2021 Jan; 200():173076. PubMed ID: 33220385
[TBL] [Abstract][Full Text] [Related]
10. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.
Silverman JL; Tolu SS; Barkan CL; Crawley JN
Neuropsychopharmacology; 2010 Mar; 35(4):976-89. PubMed ID: 20032969
[TBL] [Abstract][Full Text] [Related]
11. The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder.
Fonteneau M; Brugoux A; Jaccaz D; Donello JE; Banerjee P; Le Merrer J; Becker JA
Neuropharmacology; 2024 May; 248():109889. PubMed ID: 38401792
[TBL] [Abstract][Full Text] [Related]
12. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
[TBL] [Abstract][Full Text] [Related]
13. Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism.
Chao OY; Pathak SS; Zhang H; Dunaway N; Li JS; Mattern C; Nikolaus S; Huston JP; Yang YM
Mol Brain; 2020 Aug; 13(1):111. PubMed ID: 32778145
[TBL] [Abstract][Full Text] [Related]
14. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
[TBL] [Abstract][Full Text] [Related]
15. Restoring glutamate receptosome dynamics at synapses rescues autism-like deficits in Shank3-deficient mice.
Moutin E; Sakkaki S; Compan V; Bouquier N; Giona F; Areias J; Goyet E; Hemonnot-Girard AL; Seube V; Glasson B; Benac N; Chastagnier Y; Raynaud F; Audinat E; Groc L; Maurice T; Sala C; Verpelli C; Perroy J
Mol Psychiatry; 2021 Dec; 26(12):7596-7609. PubMed ID: 34331007
[TBL] [Abstract][Full Text] [Related]
16. Differential Adulthood Onset mGlu5 Signaling Saves Prefrontal Function in the Fragile X Mouse.
Martin HGS; Lassalle O; Manzoni OJ
Cereb Cortex; 2017 Dec; 27(12):5592-5602. PubMed ID: 27797833
[TBL] [Abstract][Full Text] [Related]
17. Sodium phenylbutyrate reduces repetitive self-grooming behavior and rescues social and cognitive deficits in mouse models of autism.
Ryu YK; Park HY; Go J; Choi DH; Choi YK; Rhee M; Lee CH; Kim KS
Psychopharmacology (Berl); 2021 Jul; 238(7):1833-1845. PubMed ID: 33723660
[TBL] [Abstract][Full Text] [Related]
18. Citalopram attenuates social behavior deficits in the BTBR T
Cai Y; Wang L; Nalvarte I; Xiao R; Li X; Fan X
Brain Res Bull; 2019 Aug; 150():75-85. PubMed ID: 31047973
[TBL] [Abstract][Full Text] [Related]
19. Icariin alleviates autistic-like behavior, hippocampal inflammation and vGlut1 expression in adult BTBR mice.
Jiang P; Zhou L; Du Z; Zhao L; Tang Y; Fei X; Wang L; Li D; Li S; Yang H; Fan X; Liao H
Behav Brain Res; 2023 May; 445():114384. PubMed ID: 36889463
[TBL] [Abstract][Full Text] [Related]
20. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder.
Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H
Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
